Vericiguat reduces atrial fibrillation recurrence by alleviating myocardial fibrosis via the TGF-beta1/Smad2/3 pathway. Sun X, Sheng Y, Xu P, Peng Q, et al. PLoS One 2025;20:e0328272.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Sun X, Sheng Y, Xu P, Peng Q, et al. Vericiguat reduces atrial fibrillation recurrence by alleviating myocardial fibrosis via the TGF-beta1/Smad2/3 pathway. PLoS One 2025;20:e0328272.
PMID: 40680000